Hallucinations are surprisingly common and varied experiences
By Emma Young
Many mentally well people experience hallucinations. An estimated 6 – 15% of us hear, see, feel or even smell things that aren’t real. But there has been little research into what those hallucinations are like — and how they might differ from those experienced by people with psychosis. Now Mascha M.J. Linszen at Utrecht University and her colleagues report the results of a large study of more than 10,000 people aged 14 to 88. The work, published in Schizophrenia, throws up a few surprises among a host of interesting findings.
The team’s online survey was open to anyone aged over 14 who ...
Source: BPS RESEARCH DIGEST - May 20, 2022 Category: Psychiatry & Psychology Authors: BPS Research Digest Tags: Perception Source Type: blogs
Sugar and Mental Health
Sugar tastes amazing and is in so many products that most people aren’t even aware of how much they are consuming daily.
Most people are aware that sugar isn’t a healthy food, but may not realize how detrimental sugar is to your overall health.
More recent research is showing a strong link between mental health and diet, suggesting that there is a two-way street between our bellies and our brains.
What has sugar in it?
When people talk about sugar, the first thing that comes to mind is the white, granulated stuff that the Brits pour into their tea.
However, there are many forms of sugar...
Source: PickTheBrain | Motivation and Self Improvement - May 17, 2022 Category: Consumer Health News Authors: Erin Falconer Tags: diet featured happiness health and fitness psychology self-improvement sugar Source Type: blogs
Study: Automated VR psychotherapy can help reduce anxiety and distress, especially among those with psychosis and severe agoraphobia
Oxford University VR spinout demonstrates significant psychotherapy benefits in Lancet study (Fierce Healthcare):
Virtual reality can help treat symptoms in patients with psychosis, according to a new study published in The Lancet Psychiatry.
GameChangeVR automates psychotherapy, guiding users with a virtual coach. It was developed by OxfordVR, a digital therapeutics company, the University of Oxford and Oxford Health NHS Foundation Trust … The study, based on 346 patients, found that automated VR therapy led to “significant reductions” in symptoms of anxious avoidance and distress. The technology especially benefite...
Source: SharpBrains - May 5, 2022 Category: Neuroscience Authors: SharpBrains Tags: Brain/ Mental Health Technology & Innovation agoraphobia cognitive cognitive model gameChange psychosis Psychotherapy virtual coach virtual-reality Source Type: blogs
Is there evidence of OMI on this ECG?
This is another one from Amandeep ( " Deep " ) Singh, with many comments by Smith. Dept Emergency Medicine, Highland Hospital, Oakland.Case67yo male with h/o schizophrenia and who has become increasingly distrustful of Western medicine presents with chest pain radiating to the right shoulder associated with shortness of breath for 24 hours duration. He states that he was unable to sleep secondary to the pain. The patient seems very worried about his right shoulder and is requesting a x-ray. An x-ray was obtained, as well as an ECG and a troponin. Prior to the trop...
Source: Dr. Smith's ECG Blog - March 26, 2022 Category: Cardiology Authors: Steve Smith Source Type: blogs
The Do ’s and Don’ts of Harnessing Technology (and Anxiety) for Good
Welcome to a new edition of SharpBrains’ e‑newsletter, featuring important brain & mental health news plus a few fun brain teasers to test your reasoning skills and more…
#1. Challenge ahead: Harnessing technology for good mental health
“Technology can not only help us grow out of unhealthy habits, it is also possible to expand human mental capacities … although it will be necessary to analyze “the how and when” of these uses: they must be ethically sound and ensure that results are beneficial to society.” — our very own Álvaro Fernández, hoping you all agree 🙂
If you prefer to read the article i...
Source: SharpBrains - February 28, 2022 Category: Neuroscience Authors: SharpBrains Tags: Brain Teasers Brain/ Mental Health Education & Lifelong Learning En Español Technology & Innovation anxiety brain-development cCBT cognitive computer-assisted cognitive behavior therapy dementia emotional Epitel hearing aids J Source Type: blogs
Otsuka and Virtual Reality start-up Jolly Good sign $43M deal to promote Social Skills Training (SST) therapies, helping schizophrenia patients first
Jolly Good and Teijin Pharma Form a Partnership to Develop VR Digital Therapeutics for Depression
Otsuka signs on Jolly Good for $43M mental health VR deal (Fierce Biotech):
The duo will build out software—hosted on Jolly Good’s VR goggles and connected tablet devices, and backed by Otsuka’s expertise in developing neurological therapeutics—that takes a social skills training (SST) approach to treating mental illness. SST is a behavioral therapy in which patients with anxiety, mood and personality disorders, among other conditions, are taught on a step-by-step basis how to navigate specific social interactions.
The...
Source: SharpBrains - February 2, 2022 Category: Neuroscience Authors: SharpBrains Tags: Brain/ Mental Health Technology & Innovation behavioral-therapy Jolly Good mental illness neurological therapeutics Otsuka pharmaceutical schizophrenia social skills training Source Type: blogs
The Hidden Emotional Sign Of Schizophrenia (M)
Schizophrenia is a serious mental disorder that involves delusions, hallucinations, problems planning and remembering, paranoia and confused thinking. (Source: PsyBlog | Psychology Blog)
Source: PsyBlog | Psychology Blog - January 12, 2022 Category: Psychiatry & Psychology Authors: Jeremy Dean Tags: Schizophrenia Source Type: blogs
On brain folding and fitting 86 billion neurons inside our 1400 cc crania
This article was originally published on The Conversation.
To learn more:
Understand your connectome, understand yourself
Understanding Brain Health via Cosmological Health, and vice versa
The post On brain folding and fitting 86 billion neurons inside our 1400 cc crania appeared first on SharpBrains. (Source: SharpBrains)
Source: SharpBrains - December 27, 2021 Category: Neuroscience Authors: The Conversation Tags: Brain/ Mental Health Biomechanics brain disorders brain folding BRAIN Initiative brain-development Cerebral Cortex computer modeling human-brain Mechanical engineering neuroimaging Neurons neuroscience white-matter Source Type: blogs
Consciousness And Climate Change: The Week ’s Best Psychology Links
Our weekly round-up of the best psychology coverage from elsewhere on the web
Recent research has found that mental health conditions like mood disorders and schizophrenia are associated with higher levels of inflammation in the body. Could this dysregulation of the immune system explain why people with these conditions are at risk of poorer Covid-19 outcomes? Brian Resnick explores the evidence at Vox.
Uncertainty can make it harder for us to make rational decisions, instead leaving us second-guessing our choices and exploring alternative options. Pandemic-induced uncertainty in particular can lead us...
Source: BPS RESEARCH DIGEST - December 3, 2021 Category: Psychiatry & Psychology Authors: BPS Research Digest Tags: Weekly links Source Type: blogs
Beacon Biosignals raises $27M to scale EEG, AI-based neurobiomarker discovery platform
Neurotech startup Beacon Biosignals scores $27M to bring AI to EEG analysis (MedCity News):
Electroencephalography is a decades-old technique for capturing brain activity, data that are used to evaluate brain disorders. Beacon Biosignals is applying artificial intelligence to these tests, and the neurotechnology startup has found a ready market in pharmaceutical companies interested in assessing how their experimental brain therapies are working. Now Beacon Biosignals has something else: $27 million in financing.
During an electroencephalogram (EEG) procedure, electrodes are affixed to the patient’s scalp. Over a period ...
Source: SharpBrains - November 17, 2021 Category: Neuroscience Authors: SharpBrains Tags: Brain/ Mental Health Technology & Innovation artificial intelligence Beacon Biosignals brain disorders brain signatures brain-activity Cumulus Neuroscience EEG EEG brain signatures electroencephalography Kernel machine-learning n Source Type: blogs
Click Therapeutics raises further $52M to build up digital therapeutics pipeline for depression, insomnia, smoking cessation and more
Getty Images
With Sanofi still on board, Click Therapeutics closes $52M series B for digital therapeutics in depression, chronic pain and more (Fierce Biotech):
Another medtech developer’s plans to create digital therapeutics to treat a wide range of illnesses are clicking into place, thanks to a third multimillion-dollar investment in Click Therapeutics in barely a year.
Click has already validated and begun the commercial launch of its first product, Clickotine, a mobile software program for smoking cessation … Several more of Click’s app-based therapeutics—all of which will require a physician’s prescription a...
Source: SharpBrains - November 4, 2021 Category: Neuroscience Authors: SharpBrains Tags: Brain/ Mental Health Technology & Innovation acute coronary syndrome app-based therapeutics chronic pain Click Therapeutics Clickadian Clickheart Clickotine cognitive cognitive-exercises depression digital therapeutics FDA cleara Source Type: blogs
Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda, Astrazeneca, Amgen And Roche
With their extending reaches, resources and influence, pharmaceutical heavyweights have the potential to shape the digital health landscape to line up with their interests. And to have a better picture of where those interests lie, it is worth taking a look at what moves pharma giants are making in this sphere. With this in mind, we started a series of articles focusing on the digital health efforts of 14 global pharma companies.
The first article explored developments coming from Johnson & Johnson, Pfizer, Bayer and Novartis, while the second article investigated those coming from Merck, GlaxoSmithKline, AbbV...
Source: The Medical Futurist - November 4, 2021 Category: Information Technology Authors: Pranavsingh Dhunnoo Tags: TMF Artificial Intelligence in Medicine Digital Health Research Future of Pharma sleep patient empowerment pharmaceutics roche MySugr Astra-Zeneca DTx takeda Boehringer Ingelheim Amgen digitisation Quire.ai Renalytix Eko Source Type: blogs
Xylological Delusions of Being a Tree
The mythology surroundingreverse inter-metamorphosis, a delusional syndrome that involves transformation into a beast, has frightened and fascinated for hundreds of years. A special instance of reverse inter-metamorphosis isclinical lycanthropy, the delusion that one has been transformed into a wolf (or another animal). A recent review identified 43 cases in the literature between 1852 and today (Guessoum et al., 2021). Psychotic depression and schizophrenia were the most common co-existing psychiatric diagnoses in these individuals.The article advocates a cultural and person-centered approach to treatment, as did many of ...
Source: The Neurocritic - October 31, 2021 Category: Neuroscience Authors: The Neurocritic Source Type: blogs
Big Pharma, Big Money: Johnson & Johnson, Pfizer, Bayer, Novartis in digital health
In a recent series of articles, we explored the latest moves of Tech Giants like Amazon, NVIDIA and Microsoft in the field of digital health. Analysing these recent developments can give us a better idea regarding where they are focusing the efforts, and how it might shape the future path of healthcare.
But equally, if not more, strong players in this field are pharmaceutical giants, as their resources and influence can significantly shape or alter the course of this path. As such, we are kickstarting a new series of articles focusing on the digital health efforts of 14 global pharma companies. While those heavywe...
Source: The Medical Futurist - October 12, 2021 Category: Information Technology Authors: Pranavsingh Dhunnoo Tags: Future of Medicine Future of Pharma digital health novartis pfizer J&J big pharma Johnson&Johnson Bayer Source Type: blogs
